117 related articles for article (PubMed ID: 9598818)
21. Gallium-68 Dotatate PET/CT is superior to other imaging modalities in the detection of medullary carcinoma of the thyroid in the presence of high serum calcitonin.
Tran K; Khan S; Taghizadehasl M; Palazzo F; Frilling A; Todd JF; Al-Nahhas A
Hell J Nucl Med; 2015; 18(1):19-24. PubMed ID: 25679074
[TBL] [Abstract][Full Text] [Related]
22. Hypercalcitoninemia in a sporadic asymptomatic neuroendocrine tumor of the pancreatic tail.
Machens A; Haedecke J; Hinze R; Thomusch O; Schneyer U; Dralle H
Dig Surg; 2000; 17(5):522-4. PubMed ID: 11124561
[TBL] [Abstract][Full Text] [Related]
23. Calcitonin-producing pancreatic somatostatinoma: report of a case.
Sugimoto F; Sekiya T; Saito M; Iiai T; Suda K; Nozawa A; Nakazawa T; Ishizaki T; Ikarashi T
Surg Today; 1998; 28(12):1279-82. PubMed ID: 9872549
[TBL] [Abstract][Full Text] [Related]
24. Calcitonin-secreting pancreatic neuroendocrine tumors: a case report and review of the literature.
Kováčová M; Filková M; Potočárová M; Kiňová S; Pajvani UB
Endocr Pract; 2014 Aug; 20(8):e140-4. PubMed ID: 24793921
[TBL] [Abstract][Full Text] [Related]
25. Neuroendocrine tumor with diarrhea: not always the usual suspects - a case report of metastatic calcitoninoma with literature review.
Vlaemynck K; De Man M; De Man K; Hoorens A; Geboes K
Acta Clin Belg; 2021 Jun; 76(3):239-243. PubMed ID: 31900071
[TBL] [Abstract][Full Text] [Related]
26. Screening for multiple endocrine neoplasia type 1 and hormonal production in apparently sporadic neuroendocrine tumors.
Baudin E; Bidart JM; Rougier P; Lazar V; Ruffié P; Ropers J; Ducreux M; Troalen F; Sabourin JC; Comoy E; Lasser P; DeBaere T; Schlumberger M
J Clin Endocrinol Metab; 1999 Jan; 84(1):69-75. PubMed ID: 9920064
[TBL] [Abstract][Full Text] [Related]
27. Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics.
Thapa P; Ranade R; Ostwal V; Shrikhande SV; Goel M; Basu S
Nucl Med Commun; 2016 Oct; 37(10):1030-7. PubMed ID: 27243215
[TBL] [Abstract][Full Text] [Related]
28. Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life.
Gonçalves TD; Toledo RA; Sekiya T; Matuguma SE; Maluf Filho F; Rocha MS; Siqueira SA; Glezer A; Bronstein MD; Pereira MA; Jureidini R; Bacchella T; Machado MC; Toledo SP; Lourenço DM
J Clin Endocrinol Metab; 2014 Jan; 99(1):E89-96. PubMed ID: 24178797
[TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics and outcome of acromegaly induced by ectopic secretion of growth hormone-releasing hormone (GHRH): a French nationwide series of 21 cases.
Garby L; Caron P; Claustrat F; Chanson P; Tabarin A; Rohmer V; Arnault G; Bonnet F; Chabre O; Christin-Maitre S; du-Boullay H; Murat A; Nakib I; Sadoul JL; Sassolas G; Claustrat B; Raverot G; Borson-Chazot F;
J Clin Endocrinol Metab; 2012 Jun; 97(6):2093-104. PubMed ID: 22442262
[TBL] [Abstract][Full Text] [Related]
30. A calcitonin-producing pancreatic neuroendocrine neoplasm treated with distal pancreatectomy a lengthy time after a left trisectionectomy for liver metastases: a case report.
Yamamoto R; Yamaguchi R; Yoshida K; Ando M; Toyoda Y; Tanaka A; Kato K
Surg Case Rep; 2022 Dec; 8(1):217. PubMed ID: 36480062
[TBL] [Abstract][Full Text] [Related]
31. The value of somatostatin-receptor scintigraphy in newly diagnosed endocrine gastroenteropancreatic tumors.
Kisker O; Bartsch D; Weinel RJ; Joseph K; Welcke UH; Zaraca F; Rothmund M
J Am Coll Surg; 1997 May; 184(5):487-92. PubMed ID: 9145069
[TBL] [Abstract][Full Text] [Related]
32. Malignant nonfunctioning endocrine tumors of the pancreas: predictive factors for survival after surgical treatment.
Chung JC; Choi DW; Jo SH; Heo JS; Choi SH; Kim YI
World J Surg; 2007 Mar; 31(3):579-85. PubMed ID: 17219270
[TBL] [Abstract][Full Text] [Related]
33. Localisation of neuroendocrine tumours of the upper gastrointestinal tract.
Zimmer T; Ziegler K; Bäder M; Fett U; Hamm B; Riecken EO; Wiedenmann B
Gut; 1994 Apr; 35(4):471-5. PubMed ID: 8174983
[TBL] [Abstract][Full Text] [Related]
34. Decreased UCHL1 expression as a cytologic biomarker for aggressive behavior in pancreatic neuroendocrine tumors.
Moore MD; Finnerty B; Gray KD; Hoda R; Liu YF; Soong L; Beninato T; Rao R; Zarnegar R; Fahey TJ
Surgery; 2018 Jan; 163(1):226-231. PubMed ID: 29150024
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors in patients with endocrine tumours of the duodenopancreatic area.
Madeira I; Terris B; Voss M; Denys A; Sauvanet A; Flejou JF; Vilgrain V; Belghiti J; Bernades P; Ruszniewski P
Gut; 1998 Sep; 43(3):422-7. PubMed ID: 9863490
[TBL] [Abstract][Full Text] [Related]
36. Well-Differentiated, Non-Functional, Non-Ampullary Duodenal Neuroendocrine Tumors: Toward Defining Evaluation and Management.
Weatherall T; Denbo J; Sharpe J; Martin M; O'Brien T; Gupta R; Groshart K; Behrman S; Dickson P
World J Surg; 2017 Mar; 41(3):844-850. PubMed ID: 27743074
[TBL] [Abstract][Full Text] [Related]
37. [Clinicopathological features of pancreatic neuroendocrine neoplasms: a retrospective analysis of 64 cases].
Yao W; Wang W; Li G
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):287-93. PubMed ID: 24989916
[TBL] [Abstract][Full Text] [Related]
38. Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1.
Thomas-Marques L; Murat A; Delemer B; Penfornis A; Cardot-Bauters C; Baudin E; Niccoli-Sire P; Levoir D; Choplin Hdu B; Chabre O; Jovenin N; Cadiot G;
Am J Gastroenterol; 2006 Feb; 101(2):266-73. PubMed ID: 16454829
[TBL] [Abstract][Full Text] [Related]
39. Analysis of somatostatin receptor 2A immunohistochemistry, RT-qPCR, and in vivo PET/CT data in patients with pancreatic neuroendocrine neoplasm.
Kaemmerer D; Wirtz RM; Fischer EK; Hommann M; Sänger J; Prasad V; Specht E; Baum RP; Schulz S; Lupp A
Pancreas; 2015 May; 44(4):648-54. PubMed ID: 25872131
[TBL] [Abstract][Full Text] [Related]
40. Recurrent Metastatic Medullary Thyroid Carcinoma: A Case of Sustained Response to Prolonged Treatment with Somatostatin Analogues.
Cano JM; Galán R; López R
Thyroid; 2017 Nov; 27(11):1450-1455. PubMed ID: 28927353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
